List of brands containing methocarbamol   

This page contains list of brands of authorized pharmaceutical specialties of the active ingredient methocarbamol in the countries listed below:

[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained on the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Methocarbamol, a carbamate derivative from guaifenesin, is a central nervous system depressant with sedative and muscle relaxant properties, which is included within the drug class of muscle relaxants.

This medication is used, along with rest, physical therapy and other appropriate measures for the relief of discomfort associated with acute musculoskeletal disorders such as sprains and strains, anywhere locomotor.

Medizzine recommends consulting your doctor if you are unsure (or you do not know) why you have been given methocarbamol.

Other ingredients of available commercial presentations:

Tablets:

The specialties containing methocarbamol may include, in addition to 400, 500 or 750 mg active substance, excipients such as corn starch, alginic acid, sodium lauryl sulfate, povidone, magnesium stearate, talc, and gelatin. The cover can include hypromellose, microcrystalline cellulose, polyoxyl 8 stearate, propylene glycol and titanium dioxide.

Injectable solution:

Besides the active ingredient (100 mg/ml), the injectable solution contains polyethylene glycol, water for injection, hydrochloric acid and sodium hydroxide. The latter two, for pH adjustment.

Warning:

The composition of the various presentations may vary from one country to another. We recommend you consult the information provided by your local supplier.

Do not use methocarbamol

If you are allergic (hypersensitive) to methocarbamol or any of the other ingredients of the medicinal product prescribed to you. If you think may be allergic, ask your doctor.

Allergy symptoms may include:

- Asthma attacks with shortness of breath, audible wheezing or rapid breathing.
- More or less sudden swelling of the face, lips, tongue or elsewhere in the body. It is especially critical if it affects the vocal cords.
- Hives, itching, rash
- Anaphylactic shock (loss of consciousness, paleness, sweating, etc.).

Nor you should take this medicine:

- If you have a history of adverse reactions to methocarbamol
- If you have previously had some brain damage or have been in a coma,
- If you suffer from epilepsy or another type of seizure,
- If you suffer from muscle weakness caused by myasthenia gravis or other neuromuscular diseases
- If you suffer from liver disease

Take special care with methocarbamol if

- You are pregnant, you think you may be pregnant or planning to become pregnant,
- If you are breastfeeding your baby
- You have or have had any liver or kidney disease
- If you're undergoing analysis. Methocarbamol may interfere with testing vanilmandelic and indoleacetic acid.

In patients with anemia, liver or kidney disorders, heart disease and lung prolonged therapy should be avoided.

Remember that your doctor has prescribed this medicine only for you. Never give it to someone else.

If in doubt, consult your doctor.

Taking other medicines

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal products or drugs obtained without a prescription.

Especially, tell your doctor or pharmacist if you are taking:

In particular, you should tell your doctor if you are taking:

- Barbiturates
- Appetite-suppressants
- Chloramphenicol, as methocarbamol increases its effects.
- Anticholinergic drugs, such as those which are used for motion sickness or certain indigestions
- Agents acting on the nervous system, such as anxiolytics, antidepressants, antipsychotic, central stimulants, etc. Methocarbamol may increase the effects of these substances.

If you will undergoing surgery which does not require hospital admission (dentistry, for example), tell your doctor or dentist you are taking methocarbamol.

Use with food and beverages

Methocarbamol may potentiate the effect of alcohol, so your should avoid drinking alcoholic beverages while being treated with this muscle relaxant.

Consult your doctor or pharmacist before taking any medicine.

Special physiological situations

Pregnancy and lactation

always consult your doctor or pharmacist before taking any medicine during pregnancy or lactation.

It is not recommended to take this medicine during pregnancy and/or lactation. However, your doctor may consider treatment with methocarbamol if the potential benefits of using outweigh the risks to the fetus or nursing infant.

Children:

Not recommended.

Elderly patients:

The administration of this drug to patients over 65 years should be made cautiously, using smaller (half usually) doses, as these patients are more sensitive to the drug and need less medicine. Also, they have a greater likelihood of adverse effects.

Driving and using machines

This medicine may cause drowsiness and decreased alertness. Do not drive or operate potentially dangerous machinery until you are sure that the medication does not affect you.

Follow carefully instructions of use of methocarbamol provided from your doctor. Consult your doctor or pharmacist when in doubt. Follow the instructions of the physician in preference to those given in this website, which may be different. Ask your doctor to explain any aspect that you do not understand, contained in the instruction leaflet that comes with the medicine.

Adults:

The usual starting dose is 1500 mg four times a day. This doses usually will be maintained a maximum 48-72 hour. Depending on the extent of disease, the doctor may increase this dose up to 8 grams daily.

Maintenance dose: 1000 mg 4 times daily.

Often a similar improvement is obtained with doses below those indicated. IN ANY CASE, the doctor will tell each patient the dose that corresponds, not only in terms of disease treatment but also taking into account the personal circumstances of each patient.

Elderly patients:

The initial and maintenance dose is half the usual adult dose. The doctor may change the dosage according to the patient's response.

Children:

Methocarbamol should not be given to children.

If you think the effect of the medicine is too strong or too weak, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

If a doctor prescribes another medicine, tell you are taking methocarbamol.

Check with your doctor regularly developments of disorder that motivates the use of methocarbamol. Maybe there is some reason that prevented you properly receive the indicated doses and induce your doctor to erroneous conclusions about treatment.

Do not restart treatment with methocarbamol at your own risk without first talking to your doctor, nor encourage its use by another person, even if have the same symptoms you have. Nor is it advisable to interrupt or reduce the dose without considering the opinion of your doctor.

If you feel unwell during treatment with methocarbamol, immediately consult your doctor.

If you take more than you should:

Methocarbamol poisoning causes abdominal pain dizziness, vomiting, and anorexia.

In the case of overdose, immediately consult your doctor or pharmacist or go to the emergency department of the nearest hospital. Take the container with you, even if it is empty.

If you forget to take methocarbamol

Take the missed dose as soon as you remember, keeping the interval between doses as advised by your doctor.

Do not take a double dose to make up for a missed dose.

If you stop taking methocarbamol

The disorder that motivates treatment with methocarbamol may worsen. Before you stop taking it, consult your doctor.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Like all medicines, methocarbamol can cause side effects although not everybody gets them.

The frequency of side effects is classified into:

The frequency of side effects is classified into:

Very common: affect 1 out of 1-10 patients
Common: affect 1 out of 10-100 patients
Uncommon: affect 1 out of 100-1.000 patients
Rare: affect 1 out of 1.000-10.000 patients
Very Rare: affect less than 1 in 10,000 patients
Incidence not known: Can not be established the true incidence from the available data

General side effects:

- Hypersensitivity reactions (allergic), including anaphylactic reactions angioedema respiratory distress
- Fever,
- Headache.

Cardiovascular side effects:

- Bradycardia,
- facial redness (hot flushes),
- Low blood pressure syncope,
- thrombophlebitis

Digestive side effects:

- Indigestíon, dyspepsia,
- Jaundice,
- Nausea and vomiting

Blood side effects:

- leukopenia.

Neurologic side effects:

- Amnesia,
- Confusion stunning
- Diplopia,
- Dizziness Vertigo
- Drowsiness insomnia sedation
- Loss of muscle coordination, ataxia,
- Nystagmus,
- Seizures

Sensory side effects:

- Blurred vision,
- Dysgeusia, metallic taste.

Other side effects:

Nasal congestion,
- Conjunctivitis,
- Pruritus (itching),
- Rashes, including urticaria.

If you notice any of the symptoms described below, should stop treatment and consult your doctor:

- Confusion
- Seizures
- Rash or swelling of the face, lips, eyelids or neck (angioedema), difficulty breathing or shortness of breath. These symptoms may be manifestations of allergy,

If you notice any of these symptoms, consult your doctor right away:

- yellowing of the skin or whites of the eyes (jaundice)

- recurrent infections or mouth ulcers. It may occur rarely a decrease of leukocytes (white blood cells), which may give rise to these symptoms.

If any of these side effects are bothersome, you must inform your doctor:

- Drowsiness, difficulty sleeping, restlessness, anxiety o concern,
- Dizziness, memory loss, rapid or unusual eye movements, blurred or double vision, red eyes, nasal congestion,
- Nausea, vomiting, heartburn, altered taste,
- Tremor, loss of muscular coordination, headache,
- Fever, itching,
- Bradycardia (slow heartbeat), flushing, fainting, decreased blood pressure.

This list does not include all adverse reactions associated with the use of methocarbamol, both well established as those that are under consideration or confirmation. In case you feel unwell, should immediately consult with the doctor who prescribed this medicine.

If you notice any side effects not listed in this website or in the leaflet accompanying the package, ask your doctor or pharmacist.

If any of the side effects gets serious, tell your doctor or pharmacist.

This page contains list of brands of authorized pharmaceutical specialties of the active principle methocarbamol in the countries listed below:

[ Australia] [ Brazil] [ Canada] [ France] [ Germany] [ India] [ Italy] [ Japan] [ Mexico] [ Pakistan] [ Puerto Rico] [ Spain] [ Turkey] [ United Kingdom] [ U.S.A]

Given the nature of the pharmaceutical market, some specialties may be unavailable, have been removed from the pharmaceutical market or have changed its name. So that, in no case can take decisions based on the information contained on the page. MEDIZZINE is not responsible for any damage arising from the information provided, which may be incomplete or outdated.

Warning:

With exceptions expressly indicated, these lists do not include active principle associations with other drugs or clinical use containers.

Australia:      ▲

N/A

Brazil:      ▲

N/A

Canada:      ▲

METHOCARBAMOL UNIVET PHARMA 100 mg/ml, injectable solution
METHOCARBAMOL OMEGA 100 mg/ml, injectable solution
PMS-METHOCARBAMOL 100 mg/ml, injectable solution
ROBAXIMOL 100 mg/ml, injectable solution
ROBAXIN 500 mg, tablets
ROBAXIN 750 mg, tablets

France:      ▲

LUMIRELAX 500 mg, 20 tablets

Germany:      ▲

ORTOTON K.I.S 100 mg/ml, injectable solution
ORTOTON 750 mg, tablets
METHOCARBAMOL OMNIAPHARM 750 mg, tablets

India:      ▲

BIGOMET 250 mg, tablets
BIGOMET 500 mg, tablets
BIGOMET 750 mg, tablets
ROBINAX 500 mg, tablets
ROBINAX 100 mg/ml, injectable solution

Italy:      ▲

N/A

Japan:      ▲

ROBAXIN gran 90%, 1 g

Mexico:      ▲

available associated with other active ingredients

Pakistan:      ▲

N/A

Spain:      ▲

ROBAXIN 500 mg, 20 tablets

Turkey:      ▲

available associated with other active ingredients

United Kingdom:      ▲

METHOCARBAMOL AAH PHARMA 750 mg, 100 tablets
METHOCARBAMOL ALLIANCE HEALTHCARE 750 mg, 100 tablets
ROBAXIN 750 mg, 100 tablets

U.S.A. and Puerto Rico:      ▲

METHOCARBAMOL LANNETT 500 & 750 mg, tablets
METHOCARBAMOL CAMBER PHARMA 500 & 750 mg, tablets
METHOCARBAMOL HETERO DRUGS 500 & 750 mg, tablets
METHOCARBAMOL MAJOR 500 & 750 mg, tablets
METHOCARBAMOL QUALITEST PHARMA 500 & 750 mg, tablets
METHOCARBAMOL SANDOZ 500 & 750 mg, tablets
METHOCARBAMOL SOLCO 500 & 750 mg, tablets
METHOCARBAMOL WATSON 500 & 750 mg, tablets
METHOCARBAMOL WEST-WARD 500 & 750 mg, tablets
METHOCARBAMOL GOLDEN STATE 500 & 750 mg, tablets
METHOCARBAMOL VIRTUS 500 & 750 mg, tablets
ROBAXIN 100 mg/ml, injectable solution
ROBAXIN 500 & 750 mg, tablets

Page updated: October 05, 2008.